Torrent Pharmaceuticals Ltd
The live share price of Torrent Pharmaceuticals Ltd (TORNTPHARM) as on 29 Sep 10:26am is ₹1,929.1 from NSE/BSE.
TORNTPHARM NSE
₹1,929.1 ▲3.51% (65.5)
As on Sep 29, 2023 03:56 PM IST
Key Metrics
PE Ratio
49.7
PB Ratio
10.18
Dividend Yield
1.18%
Sector PB
4.66
Sector PE
39.72
Sector Div Yld
0.78%
Dividend Yield
Dividend per share for the most recent financial year divided by the close price
About
Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products.
The following charts display the financial performance of the Torrent Pharmaceuticals Ltd (TORNTPHARM) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.
Furthermore, under the Peers section, you can find stocks that are similar to Torrent Pharmaceuticals Ltd (TORNTPHARM), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.
✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.
A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.
All smallcases are created and managed by SEBI-registered investment experts.
To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.
Financials
Income Statement
(INR) | Y/Y Change | |
Revenue | 9,665 Cr | +11.04% |
Operating Expense | 873 Cr | -29.79% |
Net Income | 1,245 Cr | +60.22% |
Net Profit Margin | 12.88% | +44.23% |
Earning Per Share | 36 | +60.21% |
EBITDA | 2,887 Cr | +34.72% |
Balance sheet
(INR) | Y/Y Change | |
Cash & short-term Inv | 727 Cr | +23.86% |
Total Assets | 14,609 Cr | +13.2% |
Total Liabilities | 8,411 Cr | +20.98% |
Total Equity | 6,198 Cr | +4.12% |
Shares Outstanding | 33.84 Cr | -0.01% |
Price to Book | 8.39 | +5.91% |
Return on Assets | 9.05% | +57.12% |
Return on Capital | 35.18 Cr | +41.4% |
Cash Flows
(INR) | Y/Y Change | |
Net Income | 1,245 Cr | +60.22% |
Cash from Operations | 2,368 Cr | +31.34% |
Cash from Investing | -2,335 Cr | +1090.9% |
Cash from Financing | 77 Cr | -104.34% |
Net Change in Cash | 110 Cr | -163.23% |
Free Cash Flow | 1,794 Cr | +12.11% |
Peers
SUNPHARMA
Sun Pharmaceutical Industries Ltd
PE Ratio
32.21
1Y Return
▲24.49%
CIPLA
Cipla Ltd
PE Ratio
30.21
1Y Return
▲6.3%
DRREDDY
Dr Reddy's Laboratories Ltd
PE Ratio
19.13
1Y Return
▲28.12%
MANKIND
Mankind Pharma Ltd
PE Ratio
47.88
1Y Return
▲24.06%
Latest News

Torrent Pharma - Visualising A Deal With Cipla; Key Positives, Negatives: Yes Securities Analysis
3 weeks ago on Bloomberg Quint
Change since news ▼-3.01%
Upfront, deal would require large capital outlay to buy out promoter stake followed by an open offer.

3 weeks ago on Business Today
Change since news ▼-0.37%
Kotak Institutional Equities found minimal portfolio overlap between Torrent Pharma and Cipla, thus limiting synergies

Torrent Pharma, Cipla, Sun Pharma Retain ‘Buy’ From HSBC On U.S. Demand
1 month ago on Bloomberg Quint
Change since news ▲1.48%
HSBC Global Research expects the robust growth in U.S. sales to persist.

Stocks in news: Tata Motors, Coforge, RIL, Torrent Pharma, TVS Motor and more
1 month ago on Business Today
Change since news ▲0.48%
Stocks to watch out for today: RIL, Torrent Pharma, TVS Motor, JB Pharma, Tata Motors, Coforge, Tata Communications and more

Torrent Pharma says US FDA issues ‘EIR’ for company’s manufacturing facility
1 month ago on Economic Times
Change since news ▲0.48%
Torrent Pharmaceuticals on Thursday said that the US Food and Drug Administration (US FDA) has issued an Establishment Inspection Report (“EIR”) for the company’s manufacturing facility at Dahej, Gujarat. EIR means closure of inspection.

Torrent Pharmaceuticals Gets EIR From US FDA For Dahej Facility
1 month ago on Free Press Journal
Change since news ▲0.48%
The updated classification of the site is VAI (voluntary action indicated) which indicates that Torrent will start to get approval of filed ANDAs.

How A Potential Acquisition Of Cipla Would Impact Torrent Pharma
1 month ago on Bloomberg Quint
Change since news ▲0.48%
While an official confirmation is awaited, at least two analysts said the deal may be too big for Torrent Pharma.

Torrent Pharmaceutical gains on USFDA relief for Dahej plant
1 month ago on Moneycontrol
Change since news ▲0.48%
The FDA’s ‘voluntary action indicated classification’ means that Torrent Pharma will be now able to get approval for all pending Abbreviated New Drug Applications from the site

Deal street abuzz on Torrent Pharma’s possible interest in Cipla promoter stake
1 month ago on The Hindu Businessline
Change since news ▲0.45%
Torrent Pharma shows interest in Cipla; PE players keen on buying promoter stake. If successful, it would change dynamics of domestic pharma industry. Torrent has pulled off several domestic acquisitions, incl. Elder Pharma & Unichem. Last year, bought Curatio Healthcare for Rs ₹2000 crore. Reports …

Torrent Pharma joins race to acquire stake of Cipla promoters: Report
1 month ago on Business Today
Change since news ▲2.4%
A successful deal will take Torrent Pharma to the second-largest company by revenues in India. In domestic formulation business, it will overtake market leader Sun Pharma.
FAQs on Torrent Pharmaceuticals Ltd
How to buy Torrent Pharmaceuticals Ltd stocks?
You can easily buy the stocks/shares of Torrent Pharmaceuticals Ltd (TORNTPHARM) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.
What is the Share Price of Torrent Pharmaceuticals Ltd?
The stock price of Torrent Pharmaceuticals Ltd as on 29 Sep 2023 is ₹1,929.1
What is the 52-week High and Low of Torrent Pharmaceuticals Ltd?
The 52-week high and low of Torrent Pharmaceuticals Ltd (TORNTPHARM) is ₹2,094.55 and ₹1,445.55.
What is the PE and PB ratio of Torrent Pharmaceuticals Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Torrent Pharmaceuticals Ltd are 49.7 and 10.18 respectively.
What are the peers or stocks similar to Torrent Pharmaceuticals Ltd?
The peers or stocks similar to Torrent Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Mankind Pharma Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.
Which sector does Torrent Pharmaceuticals Ltd belong to?
Torrent Pharmaceuticals Ltd (TORNTPHARM) belongs to the Pharmaceuticals sector.
What is the Market Cap of Torrent Pharmaceuticals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Torrent Pharmaceuticals Ltd (TORNTPHARM) is ₹63,072 Cr as of 29 Sep 2023
Can't decide whether or not to buy Torrent Pharmaceuticals Ltd stocks? ⭐️
Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.